Abstract
Fas (Apo-1/CD95) is a cell-surface receptor involved in cell death signaling through binding of Fas ligand. Mutation of Fas gene in lymphoid cells results in accumulation of these cells, which might thus contribute to lymphomagenesis. We examined the open reading frame of Fas cDNA in 14 cases of nasal NK/T-cell lymphoma. Mutations of Fas gene were detected in seven (50%) of 14 cases which comprised four frameshift, two missense, and one silent mutations. Frameshift mutations were caused by insertion of 1 bp (A) at nucleotide 1095 in two cases and by deletion of 1 bp at nucleotide 597 and at 704, respectively, in one each. Mouse T-cell lymphoma cells transfected with two missense mutated genes and frameshift mutations caused by insertion of 1 bp (A) at nucleotide 1095 were resistant to apoptosis induced by the anti-Fas antibody. These findings suggested that accumulation of lymphoid cells with Fas mutations provides a basis for the development of nasal NK/T-cell lymphoma.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Aozasa K, Yang WJ, Lee YB, Pan WS, Wy YF, Horiuchi K, Hyun BH, Tajima K . 1992 Int. J. Cancer 52: 673–674
Bertoni F, Conconi A, Luminari S, Realini C, Roggero E, Baldini L, Carobbio S, Cavalli F, Neri A, Zucca E . 2000 Leukemia 14: 446–448
Boldrini L, Faviana P, Pistolesi F, Gisfredi S, Di QD, Lucchi M, Mussi A, Angeletti CA, Baldinotti F, Fogli A, Simi P, Basolo F, Fontanini G . 2001 Oncogene 20: 6632–6637
Enno A, O'Rourke JL, Howlett CR, Jack A, Dixon MF, Lee A . 1995 Am. J. Pathol. 147: 217–222
Gronbaek K, Straten PT, Ralfkiaer E, Ahrenkiel V, Andersen MK, Hansen NE, Zeuthen J, Hou JK, Guldberg P . 1998 Blood 92: 3018–3024
Harabuchi Y, Yamanaka N, Kataura A, Imai S, Kinoshita T, Mizuno F, Osato T . 1990 Lancet 335: 128–130
Holm LE, Blomgren H, Lowhagen T . 1985 N. Engl. J. Med. 312: 601–604
Hongyo T, Li T, Syaifudin M, Baskar R, Ikeda H, Kanakura Y, Aozasa K, Nomura T . 2000 Cancer Res. 60: 2345–2347
Itoh N, Nagata S . 1993 J. Biol. Chem. 268: 10932–10937
Itoh N, Yonehara S, Ishii A, Yonehara M, Mizushima S, Sameshima M, Hase A, Seto Y, Nagata S . 1991 Cell 66: 233–243
Jaffe ES, Chan JK, Su IJ, Frizzera G, Mori S, Feller AC, Ho FC . 1996 Am. J. Surg. Pathol. 20: 103–111
Kato I, Tajima K, Suchi T, Aozasa K, Matsuzuka F, Kuma K, Tominaga S . 1985 Jpn. J. Cancer Res. 76: 1085–1090
Landowski TH, Qu N, Buyuksal I, Painter JS, Dalton WS . 1997 Blood 90: 4266–4270
Lee SH, Shin MS, Park WS, Kim SY, Dong SM, Pi JH, Lee HK, Kim HS, Jang JJ, Kim CS, Kim SH, Lee JY, Yoo NJ . 1999a Cancer Res. 59: 3068–3072
Lee SH, Shin MS, Park WS, Kim SY, Kim HS, Han JY, Park GS, Dong SM, Pi JH, Kim CS, Kim SH, Lee JY, Yoo NJ . 1999b Oncogene 18: 3754–3760
Li T, Hongyo T, Syaifudin M, Nomura T, Dong Z, Shingu N, Kojya S, Nakatsuka S, Aozasa K . 2000 Lab. Invest. 80: 493–499
Malkhosyan S, Rampino N, Yamamoto H, Perucho M . 1996 Nature 382: 499–500
Markowitz S, Wang J, Myeroff L, Parsons R, Sun L, Lutterbaugh J, Fan RS, Zborowska E, Kinzler KW, Vogelstein B . 1995 Science 268: 1336–1338
Mizushima S, Nagata S . 1990 Nucleic Acids Res. 18: 5322
Muschen M, Re D, Brauninger A, Wolf J, Hansmann ML, Diehl V, Kuppers R, Rajewsky K . 2000 Cancer Res. 60: 5640–5643
Ng CS, Lo ST, Chan JK . 1999 Hum. Pathol. 30: 48–53
Ohsawa M, Nakatsuka S, Kanno H, Miwa H, Kojya S, Harabuchi Y, Yang WI, Aozasa K . 1999 Int. J. Cancer 81: 865–870
Park WS, Oh RR, Kim YS, Park JY, Lee SH, Shin MS, Kim SY, Kim PJ, Lee HK, Yoo NY, Lee JY . 2001 J. Pathol. 193: 162–168
Parsons R, Myeroff LL, Liu B, Willson JK, Markowitz SD, Kinzler KW, Vogelstein B . 1995 Cancer Res. 55: 5548–5550
Rampino N, Yamamoto H, Ionov Y, Li Y, Sawai H, Reed JC, Perucho M . 1997 Science 275: 967–969
Seeberger H, Starostik P, Schwarz S, Knorr C, Kalla J, Ott G, Muller HH, Greiner A . 2001 Lab. Invest. 81: 977–986
Souza RF, Appel R, Yin J, Wang S, Smolinski KN, Abraham JM, Zou TT, Shi YQ, Lei J, Cottrell J, Cymes K, Biden K, Simms L, Leggett B, Lynch PM, Frazier M, Powell SM, Harpaz N, Sugimura H, Young J, Meltzer SJ . 1996 Nat. Genet. 14: 255–257
Suda T, Takahashi T, Golstein P, Nagata S . 1993 Cell 75: 1169–1178
Takakuwa T, Dong Z, Takayama H, Matsuzuka F, Nagata S, Aozasa K . 2001 Cancer Res. 61: 1382–1385
Weiss LM, Jaffe ES, Liu XF, Chen YY, Shibata D, Medeiros LJ . 1992 Blood 79: 1789–1795
Wotherspoon AC, Doglioni C, Diss TC, Pan L, Moschini A, de Boni M, Isaacson PG . 1993 Lancet 342: 575–577
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Takakuwa, T., Dong, Z., Nakatsuka, S. et al. Frequent mutations of Fas gene in nasal NK/T cell lymphoma. Oncogene 21, 4702–4705 (2002). https://doi.org/10.1038/sj.onc.1205571
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1205571
Keywords
This article is cited by
-
The broad and challenging landscape of extranodal lymphoproliferations
Virchows Archiv (2020)
-
Molecular pathogenic pathways in extranodal NK/T cell lymphoma
Journal of Hematology & Oncology (2019)
-
Aggressive natural killer-cell leukemia mutational landscape and drug profiling highlight JAK-STAT signaling as therapeutic target
Nature Communications (2018)
-
Molecular Pathogenesis of Peripheral T Cell Lymphoma
Current Hematologic Malignancy Reports (2015)
-
Activating mutations of STAT5B and STAT3 in lymphomas derived from γδ-T or NK cells
Nature Communications (2015)